Peng M, Zhang S, Wu P, Hou X, Wang D, Ge J
Mol Cancer. 2025; 24(1):67.
PMID: 40050914
PMC: 11884054.
DOI: 10.1186/s12943-025-02272-3.
Lin Y, Wang Y, Li L, Zhang K
Genes Dis. 2025; 12(3):101347.
PMID: 40034125
PMC: 11875173.
DOI: 10.1016/j.gendis.2024.101347.
Wang S, Wu C, Wang J, Yuan F, Hou Y, Cao T
J Transl Med. 2025; 23(1):250.
PMID: 40022084
PMC: 11871676.
DOI: 10.1186/s12967-025-06226-7.
Tan S, Yang W, Ren Z, Peng Q, Xu X, Jiang X
J Hematol Oncol. 2025; 18(1):20.
PMID: 39972384
PMC: 11841355.
DOI: 10.1186/s13045-025-01671-9.
Hatzimanolis O, Sykes A, Cristino A
Mol Psychiatry. 2025; .
PMID: 39966624
DOI: 10.1038/s41380-025-02925-1.
Regulatory role of circular RNAs in the development of therapeutic resistance in the glioma: A double-edged sword.
Masoomabadi N, Gorji A, Ghadiri T, Ebrahimi S
Iran J Basic Med Sci. 2025; 28(1):3-15.
PMID: 39877636
PMC: 11771335.
DOI: 10.22038/ijbms.2024.81644.17669.
A novel peptide encoded by circSRCAP confers resistance to enzalutamide by inhibiting the ubiquitin-dependent degradation of AR-V7 in castration-resistant prostate cancer.
Meng X, Wu Q, Cao C, Yang W, Chu S, Guo H
J Transl Med. 2025; 23(1):108.
PMID: 39844192
PMC: 11755828.
DOI: 10.1186/s12967-025-06115-z.
The Role of the Dysregulation of circRNAs Expression in Glioblastoma Multiforme.
Wang Y, Yu Y, Yu J, Wang C, Wang Y, Fu R
J Mol Neurosci. 2025; 75(1):9.
PMID: 39841303
DOI: 10.1007/s12031-024-02285-5.
Genetically Engineered Brain Organoids Recapitulate Spatial and Developmental States of Glioblastoma Progression.
Ishahak M, Han R, Annamalai D, Woodiwiss T, McCornack C, Cleary R
Adv Sci (Weinh). 2025; 12(10):e2410110.
PMID: 39836549
PMC: 11905097.
DOI: 10.1002/advs.202410110.
Comprehensive discovery and functional characterization of the noncanonical proteome.
Shi C, Liu F, Su X, Yang Z, Wang Y, Xie S
Cell Res. 2025; 35(3):186-204.
PMID: 39794466
DOI: 10.1038/s41422-024-01059-3.
The protein circPETH-147aa regulates metabolic reprogramming in hepatocellular carcinoma cells to remodel immunosuppressive microenvironment.
Lan T, Gao F, Cai Y, Lv Y, Zhu J, Liu H
Nat Commun. 2025; 16(1):333.
PMID: 39747873
PMC: 11696079.
DOI: 10.1038/s41467-024-55577-0.
DUSP3 restrains the progression and stemness property of osteosarcoma through regulating EGFR/STAT3/SOX2 axis.
Wei Z, Zheng D, Xia K, Huang X, Liu W, Wei Z
Int J Biol Sci. 2025; 21(1):160-174.
PMID: 39744427
PMC: 11667805.
DOI: 10.7150/ijbs.101137.
A Review on Circular RNA Translation and Its Implications in Disease.
Wei H, Fan X, Mao M
Methods Mol Biol. 2024; 2883:109-137.
PMID: 39702706
DOI: 10.1007/978-1-0716-4290-0_5.
Translation of circular RNAs.
Margvelani G, Maquera K, Welden J, Rodgers D, Stamm S
Nucleic Acids Res. 2024; 53(1.
PMID: 39660652
PMC: 11724312.
DOI: 10.1093/nar/gkae1167.
Circ_0001944 Targets the miR-1292-5p/FBLN2 Axis to Facilitate Sorafenib Resistance in Hepatocellular Carcinoma by Impeding Ferroptosis.
Jing F, Shi Y, Jiang D, Li X, Sun J, Guo Q
Immunotargets Ther. 2024; 13:643-659.
PMID: 39624827
PMC: 11611519.
DOI: 10.2147/ITT.S463556.
Targeting Glycolytic Reprogramming in Cholangiocarcinoma: A Novel Approach for Metabolic Therapy.
Hao L, Li S, Peng Q, Zhang J, Deng J, Hu X
J Inflamm Res. 2024; 17:9665-9681.
PMID: 39618935
PMC: 11606715.
DOI: 10.2147/JIR.S497551.
Androgen-targeted hsa_circ_0085121 encodes a novel protein and improves the development of prostate cancer through facilitating the activity of PI3K/Akt/mTOR pathway and enhancing AR-V7 alternative splicing.
Li J, Qiu H, Dong Q, Yu H, Piao C, Li Z
Cell Death Dis. 2024; 15(11):848.
PMID: 39567496
PMC: 11579034.
DOI: 10.1038/s41419-024-07246-9.
The crosstalk between alternative splicing and circular RNA in cancer: pathogenic insights and therapeutic implications.
Hu H, Tang J, Wang H, Guo X, Tu C, Li Z
Cell Mol Biol Lett. 2024; 29(1):142.
PMID: 39550559
PMC: 11568689.
DOI: 10.1186/s11658-024-00662-x.
Synthetic circRNA therapeutics: innovations, strategies, and future horizons.
Cai J, Qiu Z, Cho W, Liu Z, Chen S, Li H
MedComm (2020). 2024; 5(11):e720.
PMID: 39525953
PMC: 11550093.
DOI: 10.1002/mco2.720.
CircSP3 encodes SP3-461aa to promote ccRCC progression via stabilizing MYH9 and activating the PI3K-Akt signaling pathway.
Wu X, Sun G, Fan R, Liu K, Duan C, Mao X
J Cancer. 2024; 15(18):5876-5896.
PMID: 39440063
PMC: 11493002.
DOI: 10.7150/jca.100706.